Ionis Angioedema Drug Shows Positive Results in Phase 3 Trial (NASDAQ:IONS) by Technical Terrence Team 01/22/2024 0 Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...
A new method for evaluating the performance of models trained on synthetic data when applied to real-world data 01/22/2023